# A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects

> **NCT05642377** · PHASE1 · UNKNOWN · sponsor: **Glaceum** · enrollment: 40 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** HGR4113
- **DRUG:** Placebo
- **DRUG:** HGR4113
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05642377
- **Lead sponsor:** Glaceum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-22
- **Primary completion:** 2024-07-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642377, "A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05642377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*